Recent Headlines
Within Health Care Products
Thrombolex, Inc. Awarded 2-Year Agreement with Premier, Inc. for Hybrid Endovascular Catheter for the Treatment of VTE
Thrombolex, Inc. has been awarded a group purchasing agreement with Premier Inc., effective December 1, 2022. The new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for the BASHIR™ Endovascular Catheters. The... - December 15, 2022 - Thrombolex, Inc.
Paras Biopharma Streamlines Offerings as “Biologics CDMO” and Biosimilar Co-Development as “Paras Biologics”
Paras Biopharmaceuticals Finland Oy today revealed that the company has streamlined and enhanced its business activities with the establishment of a division called, Paras Biologics. In addition to its existing biologics CDMO activities and capabilities (this division is now referred to as Paras Biopharma), the creation of Paras Biologics enhances the company’s biologics and biosimilar pipeline for co-development and licensing opportunities. - December 11, 2022 - Paras Biopharmaceuticals Finland Oy
Black Forest Ham Specialities Stay Fresh Longer Thanks to Modern Vacuum Packaging by Busch Vacuum Solutions
In 2021, the central vacuum system was due to be expanded. Consumer demand has increased significantly and more and more packaging machines have been used at Schwarzwaldhof. As a result, the demand for vacuum also increased. The new system consists of MINK claw vacuum pumps, COBRA screw vacuum pumps and PANDA vacuum boosters. - December 11, 2022 - Busch Vacuum Solutions
Pathfinder Health Launches Social Awareness Campaign to Draw Attention to The Gaps in Pediatric Care
This campaign will focus on raising awareness of the alarming statistics surrounding children's developmental delays: 28% of children are at-risk for developmental delays, and only 1/5 of those with delays receive early intervention. - December 09, 2022 - Pathfinder Health
Thrombolex Announces Publication in the Journal of the American College of Cardiology, Cardiovascular Interventions
Thrombolex Releases the Results of the RESCUE Pivotal Trial for the Treatment of Acute Pulmonary Embolism (PE) with the BASHIR™ Endovascular Catheter. - December 08, 2022 - Thrombolex, Inc.
PharmStars Announces Fall 2022 Accelerator Graduates: 11 Digital Health Startups Complete PharmStars’ Pharma-Focused Accelerator Program
PharmStars, the pharma-focused accelerator for digital health startups, announces the graduation of 11 startups from its Fall 2022 program focused on “Innovations in Real-World Evidence.” The graduating startups successfully completed PharmaU, PharmStars’ 10-week education, and mentoring program. PharmaU culminated with a Showcase Event--held in Boston in early November--that brought together the participating startups and PharmStars’ seven innovation-minded pharma members. - December 08, 2022 - PharmStars
IVL Creates New Supplement for Optimized Nitric Oxide Support and Better Blood Flow
4 ingredients to support the body's production of Nitric Oxide, a vital molecule for maintaining healthy muscles and blood vessels. - December 08, 2022 - IVL.com
PharmStars Announces “Innovations in Women’s Health and Health Equity” Theme for Spring 2023 Accelerator
PharmStars, the pharma-focused accelerator for digital health startups, is now accepting applications for its Spring 2023 cohort with the theme “Digital Innovations in Women’s Health and Health Equity.” Startups with digital innovations that promote more equitable, inclusive healthcare for underserved population or focused on women’s health (e.g., breast, ovarian, and cervical cancer; gynecological conditions; osteoporosis; menopausal, hormonal, and reproductive conditions) are welcome to apply. - December 05, 2022 - PharmStars
Clinical Research Organization, Huntington Study Group “Firsts” Continue
The Huntington Study Group (HSG), a world leader in conducting clinical trials for Huntington’s Disease (HD) through its Clinical Research Organization (CRO), HSG Clinical Research, Inc. (HSGCR) continues making groundbreaking progress in the HD world. At their Annual Meeting in November, the... - December 05, 2022 - Huntington Study Group
Another Record-Breaking Fiscal Year for HME Home Health, Canada’s Fastest-Growing Dealer - HME Leadership Team Provides Quarterly Update
HME Home Health, British Columbia’s rapidly-growing home-medical equipment company, is pleased to report another record-breaking fiscal year – along with plans for continued growth in 2023. Starting from a single location in B.C.’s Lower Mainland, HME has expanded aggressively... - December 03, 2022 - HME Home Health
CareSmartz360 Brings Out New App Features to Enhance User Experience
CareSmartz360 strives to push the limits of possibilities and bring out the best software for its users. The recent software update release features some advancements to the Agency mobile app and caregiver mobile app for users. - December 02, 2022 - Caresmartz, Inc.
UserWise, LLC Launches Its First eLearning Catalog
UserWise, LLC, a San Jose, California-based Human Factors consultancy, has launched UserWise University, another step towards helping develop safe and usable medical devices. - December 01, 2022 - UserWise, LLC
Transtek Participated in the Medica2022 on November 14-17, 2022. The Event Was Hosted at Am Staad (Stockumer Höfe), D-40474 Düsseldorf, Germany.
On November 14-17, 2022, Transtek participated in Medica2022. The event was hosted at Am Staad (Stockumer Höfe), D-40474 Düsseldorf, Germany. Transtek's flagship products and new products such as 4G blood pressure monitors, 4G blood glucose meters and 4G weight scales, as well as... - November 30, 2022 - Transtek
Vesalio Appoints VP of U.S. Sales and Announces Recent Publication on NeVa Showing Impressive First Pass Rates
Vesalio hires Bob Bushok as VP of U.S. Sales and announces high first-pass rates and favorable safety profile in a 145-stroke patient data set for the NeVa™ thrombectomy device with findings published in the journal Interventional Neuroradiology. - November 29, 2022 - Vesalio
Paras Biopharmaceuticals Finland Oy is Highly Recommended for Biologics CDMO – Development / Scale-up & Production of Biologics by Innovative USA Biopharma Company
Paras Biopharmaceuticals is pleased to announce that the company has been highly recommended for its Biologics CDMO – development / scale-up and production capabilities. The Paras Biopharmaceuticals Team has successfully completed multiple biologics projects in 2022. - November 29, 2022 - Paras Biopharmaceuticals Finland Oy
Huntington Study Group Annual Meeting
The Huntington Study Group (HSG), a world leader in conducting clinical trials for Huntington’s Disease (HD), recently held its 29th Annual Meeting in Tampa, FL. This renowned meeting brings together HD thought leaders, scientific experts, industry partners and sponsors, advocacy groups, and... - November 29, 2022 - Huntington Study Group
Marty Rosenberg joins the Board of Scientific Advisors at Microvascular Therapeutics.
Microvascular Therapeutics (MVT), a clinical stage biotechnology company based in Tucson, Arizona, announced the appointment of Marty Rosenberg to the MVT Board of Scientific Advisors. Mr. Rosenberg brings a broad experience with the clinical development and global regulatory approval process for... - November 25, 2022 - Microvascular Therapeutics, Inc.
David Lim Joins the Team at Microvascular Therapeutics as Director of Finance
Microvascular Therapeutics (MVT), a clinical stage biotechnology company based in Tucson, Arizona, announced the appointment of David Lim as Director of Finance at MVT. Mr. Lim brings a broad experience with the business development and strategic financing for diagnostic pharmaceuticals across all... - November 25, 2022 - Microvascular Therapeutics, Inc.
Novugen Pharma Became the First Pharmaceutical Company in Malaysia to Receive USFDA Approval for Its Manufacturing Facility
The Company was audited in September 2022 and USFDA issued an Establishment Inspection Report (EIR) in November 2022. Novugen Pharma is the first USFDA approved pharmaceutical manufacturing in Malaysia and the only in Southeast Asia. - November 22, 2022 - Novugen
Introducing MIRAPeel MD, the Only 6-in-1 Clinical-Grade Skincare Platform of Its Kind
Attention Dermatologists, Plastic Surgeons and Med Spa Owners: Meet MIRAPeel MD, the one stop shop for all skin needs, and the first of its kind. Offering 6 treatments in one, MIRAPeel MD is setting a new treatment standard for skin care specialists, medical spas, dermatology and plastic surgery offices. - November 22, 2022 - eMIRAmed
Immunodominant Announces Call for Initial Investment Round as Company Prepares for Phase 2 Study of Oral OTC COVID-19 Drug
Immunodominant Inc., a drug discovery and development company engaged in progressing innovative research from academia to commercialization, today announced its intention to begin an initial financing round of up to $30 million. Immunodominant also announced today that it is scheduling a Phase 2 clinical study after a pre-IND meeting with the FDA for LACTOVID, a novel, oral, over-the-counter drug for the prevention and treatment of COVID-19. - November 20, 2022 - Immunodominant
Biomed Industries, Inc. Comments on Roche’s Alzheimer’s Phase III Trial
In a news release dated November 14, 2022, Roche announced that their Alzheimer’s drug candidate, gantenerumab, did not perform meaningfully better than a placebo. About 25% of all patients who received gantenerumab were also associated with higher rates of an imaging abnormality that can... - November 19, 2022 - Biomed Industries Inc.
Securisyn Medical awarded $249,750 Advanced Industries Early Stage Capital and Retention Grant from the Colorado Office of Economic Development and International Trade
Securisyn Medical, an early commercial-stage medical technology company and the developer of the patented SolidAIRity Flex® Oral Endotracheal Tube Stabilizer System, announced today the Colorado Office of Economic Development and International Trade has awarded the Company a $249,750 Early Stage Capital and Retention Grant to accelerate design freeze, verification and validation testing, and clinical builds for the Company’s patented chest tube tube seal and securement device, SolidAIRity CT™. - November 18, 2022 - Securisyn Medical
Microvascular Therapeutics Receives Funds from the National Cancer Institute (NCI) for Its Brain Tumor Program
Microvascular Therapeutics (MVT), a clinical stage biotechnology company based in Tucson, AZ, was recently awarded a Phase I Small Business Innovation Research grant from the National Cancer Institute (NCI). Emmanuelle Meuillet, Chief Scientific and Operating Officer at MVT said, “We are... - November 18, 2022 - Microvascular Therapeutics, Inc.
Prosel Bioscience Becomes One Cell Foods and Names Dr. Scott Jenkins Its New CEO
One Cell Food, Inc will focus on scaling its proprietary bioreactor design to commercialize developed strains for its first food product by early 2023. As the new CEO, Dr. Scott Jenkins will lead the operation and fundraising efforts. - November 17, 2022 - One Cell Foods, Inc.
Foam Swab Manufacturer Super Brush LLC Will be Exhibiting at the 2022 COMPAMED/MEDICA International Trade Fair
US-based Super Brush LLC is pleased to announce that they will be exhibiting at this year's COMPAMED International Trade Fair, to be held November 14th-17th, 2022 in Dusseldorf, Germany. COMPAMED is a leading international trade fair and is held in parallel with the MEDICA tradeshow. The team will... - November 13, 2022 - Super Brush LLC
Foam Swab Manufacturer Super Brush LLC Will be Exhibiting at the 2022 AEMS (Anaheim Electronics & Manufacturing Show)
US-based Super Brush LLC is pleased to announce that they will be exhibiting at this year's AEMS (Anaheim Electronics & Manufacturing Show), to be held November 16th-17th, 2022 in Anaheim, California at the Anaheim Convention Center. AEMS is a Design & Manufacturing show for the... - November 13, 2022 - Super Brush LLC
Families of World War II Veterans Holds 2022 Fundraising Golf Tournament
Families of World War II Veterans held its annual golf tournament and fundraising event on Monday, October 24, at the award-winning Trinity Forest Golf Club in Dallas, Texas, the former home of the renowned AT&T Byron Nelson tournament. This is the organization’s biggest fundraising event... - November 12, 2022 - Careington
New Division Set on Redefining Advertising for Those 50+
The Salt Division of the 1.11 Group is a new division set on redefining advertising for those 50+ and combating ageism in advertising. - November 11, 2022 - 1.11 Group/The Salt Division
Are You Ready to Get Shroomed?
After a historical win for the war on drugs in Colorado, the state and the nation begins to look at ways to implement Magic Mushroom assisted therapy along with other plant medicine. We look at the facts behind this, and what it means for you. - November 11, 2022 - shroomed
Nuvem, a Leading Pharmacy Technology & Services Company, Appoints New CEO
Nuvem (or the “Company”), a high-growth, healthcare technology company offering an integrated suite of pharmacy claims administration technology, related analytics and onsite pharmacy management services to safety net healthcare providers, announced that Matthew Umscheid has joined the... - November 10, 2022 - Nuvem
Eminent Spine's ALIF Stand-Alone System Receives FDA 510(K) Clearance in October 2022
Eminent Spine's ALIF Stand-Alone System includes PEEK and 3D Printed Titanium footprints. The implants are offered as non-sterile. - November 08, 2022 - Eminent Spine
PharmStars Announces Fall 2022 Startup Showcase Event
PharmStars, the pharma-focused accelerator for digital health startups, announces that its Fall 2022 Showcase Event will begin on November 8, 2022. The Showcase is the culmination of a 10-week startup accelerator program. At the Showcase Event, startups will make formal presentations to and meet... - November 08, 2022 - PharmStars
ISEMED and Arazy Group Sign Agreement for Advanced Regulatory Affair Technology
Global market access is now available to the Italian Medtech and IVD industry using advanced regulatory affair technology and management platforms. ISEMED (Imola, Italy) had signed a representation agreement with Arazy Group Consultant (Vancouver, BC, Canada) to become the Italian representative of Arazy's advanced regulatory affair technology, SaaS system and software specifically designed for medical and IVD device manufacturers. - November 08, 2022 - Arazy Group
Biomed Industries, Inc. (“Biomed”) Today Announced the Closing of Its Merger with MedAware Systems, Inc., (“MedAware”)
Biomed Industries, Inc. (“Biomed”) today announced the closing of its merger with MedAware Systems, Inc., (“MedAware”), in which all issued and outstanding common shares of capital stock of MedAware will be exchanged for common stock of Biomed at a ratio of 5.33 shares of MedAware for 1 new common share of Biomed. The transaction valued at an aggregate of $20 million, to be paid by 2,259,170 common shares of Biomed. At present, Biomed has approximately 76,354,075 common shares issued. - November 07, 2022 - Biomed Industries, Inc.
Thrivous Launches Vitality Geroprotector Formula 2
Thrivous, the human enhancement company, has released Vitality Geroprotector Formula 2 with Mirtoselect® Blueberry Anthocyanin. Vitality is the advanced geroprotector supplement that Thrivous develops to enhance metabolism and cell function for better aging. Vitality combines geroprotector... - November 07, 2022 - Thrivous
New Pivotal Data Demonstrates Clinical Feasibility of GeneFluidics’ Direct-from-Specimen AST in Clinical Settings
GeneFluidics, Inc. is pleased to announce a joint publication with the Medical College of Wisconsin (MCW) that introduces rapid antimicrobial susceptibility testing (AST), which would represent a paradigm shift in the clinical management of microbial infections. The data from the MCW study have... - November 04, 2022 - GeneFluidics Inc.
Thaddeus Medical Customizable Cold-Chain iQ-Ler Now Available for Pre-Order
Cold Chain system is designed for storage, transportation and dispensary of temperature-sensitive medical therapeutics to eliminate all spoilage in cold-chain logistics and improve patient outcomes - November 03, 2022 - Thaddeus Medical
GenRocket Welcomes Karthik Loganathan, Chief Customer Officer, to Accelerate Growth and Adoption of Synthetic Data Platform
The leading synthetic data automation company adds customer-focused executive leadership underscoring a strong commitment to exceptional service during a stage of accelerated growth. - November 03, 2022 - GenRocket, Inc.
Veed Network Unveils License Badging Feature to Battle Illicit Trade in Cannabis
Veed Badges provide verification of the license type and active status for all brands on the Veed Network platform. - November 03, 2022 - Veed, Inc.
Securisyn Medical seeks up to $5 Million Crowd SAFE Raise for Commercialization of its Clinically Differentiated Ventilated Patient Safety Technology Platform
Securisyn Medical, LLC (“Securisyn Medical” or the “Company”) is a commercial-stage medical technology company and the developer of the patented SolidAIRity Flex® Oral Endotracheal Tube Stabilizer System, announced today the launch of its $5 Million Crowd SAFE... - November 02, 2022 - Securisyn Medical
DistillerSR Launches New CuratorCR Capabilities to More Dynamically Manage and Reuse Evidence-Based Research
CuratorCR Knowledge Center Provides Alternative to Elsevier’s QUOSA Virtual Library as Its Sunset Date Looms. - October 31, 2022 - DistillerSR
Meet with the Leaders in Foam Swab Technology at This Year’s SEMA Show on November 1-4, 2022, in Booth 12769
Super Brush LLC will be showcasing its new line of lint-free foam swabs for restyling and car care detailing at this year’s SEMA Show. The team will be in booth 12769, located in the North Hall at the Las Vegas Convention Center on November 1-4, 2022. Super Brush is a US-based manufacturer... - October 28, 2022 - Super Brush LLC
MoBagel Launches New End-to-End AI Solution for Supply Chain at MedTech Conference in Boston
Today at 2022 MedTech Conference in Boston from 2:20pm to 2:40pm at Solutions Showcase, Iru will illustrate how to utilize Decanter AI End-to-End to swiftly build a smart solution and to discuss how auto ML can ensure resilient health care supply chains in this post pandemic world. - October 27, 2022 - MoBagel
Community Wellness Opening 24x7 Patient Monitoring and Training Facility in Danville, Kentucky
Kentucky Commonwealth Governor Andy Beshear to Speak at the Ribbon Cutting ceremony of Community Wellness's 24x7 Patient Monitoring and Training Facility in Danville, Kentucky. - October 26, 2022 - Community Wellness
Glo-Med Networks Launches New Website
The new Glo-Med Networks website is live. Glo-Med Networks is very excited to announce the launch of their fully re-designed website showcasing their line of next generation medical devices in an easy to navigate format. The website features an ever-expanding product line including: - Lenexa... - October 25, 2022 - Glo-Med Networks
Gallant Announces Hiring of John Klacking, Ph.D. as Chief Business Officer
Furthering its regenerative medicine therapeutics research and development, animal biotech company Gallant welcomes a pioneer in the biotech space. - October 25, 2022 - Gallant
UTECH® Products Expands Operations to Abu Dhabi, Totaling Eight International Offices
UTECH® Products Inc., a medical and laboratory equipment and supplies company is pleased to announce expanding operations to Abu Dhabi, United Arab Emirates, making it its 8th office worldwide. UTECH is bringing its expansive offerings to the Middle East market as a global leader in medical... - October 25, 2022 - EndoSoft
Huntington Study Group Announces Results from the HD-Net Assessment on the State of Care for Huntington’s Disease in the United States
The Huntington Study Group (HSG), a world leader in clinical research for Huntington’s Disease (HD) for over 30 years, is pleased to announce the results from the novel HD-Net survey, which examined the United States Huntington’s disease (HD) care delivery in a variety of clinic settings by HD specialists and non-specialists. - October 25, 2022 - Huntington Study Group
Minus K Technology Announces Announces Its Seventh U.S. Educational Giveaway of Vibration Isolators to Colleges and Universities
As Minus K celebrates their upcoming 30 years in business, they are giving away $25,000* dollars worth of passive mechanical patented superior performing negative-stiffness low-frequency vibration isolators to colleges in the United States. - October 25, 2022 - Minus K Technology Inc.